Mike W. Helms

826 citations

21 papers · 591 indexed · h-index 13

Cancer Research
Immunology
- Immune Response and Inflammation 2
Oncology
- HER2/EGFR in Cancer Research 2
Molecular Biology
- RNA Interference and Gene Delivery 4
- Advanced biosensing and bioanalysis techniques 4
- RNA Research and Splicing 2
- Gene expression and cancer classification 2
Biophysics
- Cell Image Analysis Techniques 2
Genetics
- Estrogen and related hormone effects 2

Co-authors: Burkhard Brandt Christopher H. Contag Horst Buerger Werner Boecker Jens Packeisen Christos Tsatsanis Christina Doxaki Birgit Schittek
Cited by: Cancer Research Immunology Oncology
Journals: The Journal of Immunology (2 papers)Journal of Molecular Biology (1 paper)Cancer Research (1 paper)
Partner nations: Germany United States Belgium

In The Last Decade

Mike W. Helms

20 papers receiving 585 citations

Peers

Countries citing papers authored by Mike W. Helms

Since Specialization

Citations

This map shows the geographic impact of Mike W. Helms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike W. Helms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike W. Helms more than expected).

Fields of papers citing papers by Mike W. Helms

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike W. Helms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike W. Helms. The network helps show where Mike W. Helms may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mike W. Helms, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mike W. Helms Line = papers co-authored together Mike W. Helms links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Trivalent siRNA-Conjugates with Guanosine as ASGPR-Binder Show Potent Knock-Down In Vivo Journal of Medicinal Chemistry ·Armin Hofmeister,Kerstin Jahn‐Hofmann,Bodo Brunner,Mike W. Helms,Christiane Metz-Weidmann,Christoph Poeverlein,Gernot Zech,Ziyu Li,Gerhard Heßler,Herman Schreuder,Bettina Elshorst,Arne Krack,Michael Kurz,Christoph Heubel,Sabine Scheidler	2025	0
2	Small Interfering RNAs Containing Dioxane- and Morpholino-Derived Nucleotide Analogues Show Improved Off-Target Profiles and Chirality-Dependent In Vivo Knock-Down Journal of Medicinal Chemistry ·Armin Hofmeister,Kerstin Jahn‐Hofmann,Bodo Brunner,Mike W. Helms,Christiane Metz-Weidmann,Arne Krack,Michael Kurz,Christoph Heubel,Sabine Scheidler	2022	4
3	Syntheses of Morpholine-Based Nucleotide Analogs for Hepatic siRNA Targeting and Stabilization Journal of Medicinal Chemistry ·Armin Hofmeister,Kerstin Jahn‐Hofmann,Bodo Brunner,Mike W. Helms,Christiane Metz-Weidmann,Arne Krack,Michael Kurz,Ziyu Li,Merle M. Weitzenberg,Elsa Pflimlin,Oliver Plettenburg,Sabine Scheidler	2021	4
4	Nanobody–siRNA Conjugates for Targeted Delivery of siRNA to Cancer Cells Molecular Pharmaceutics ·Oleksandr Zavoiura,Bodo Brunner,Peter Casteels,Luciana Teixeira Zimmermann,Matthias Ozog,Carlo Boutton,Mike W. Helms,Timothy R. Wagenaar,Volker Adam,Josefine Peterka,Christiane Metz-Weidmann,Pieter Deschaght,Sabine Scheidler,Kerstin Jahn‐Hofmann	2021	23
5	Engagement of community stakeholders to develop a framework to guide research dissemination to communities Health Expectations ·Jennifer Cunningham‐Erves,Tilicia Mayo‐Gamble,Yolanda Vaughn,Jim Hawk,Mike W. Helms,Claudia Barajas,Yvonne Joosten	2020	21
6	Utility of the RIG-I Agonist Triphosphate RNA for Melanoma Therapy Molecular Cancer Therapeutics ·Mike W. Helms,Kerstin Jahn‐Hofmann,Felix Gnerlich,Christiane Metz-Weidmann,Monika Braun,Gabriele Dietert,Petra Scherer,Kaj Grandien,Joachim Theilhaber,Hui Cao,Timothy R. Wagenaar,Max Schnurr,Stefan Endres,Dmitri Wiederschain,Sabine Scheidler,Simon Rothenfußer,Bodo Brunner,Lars M. König	2019	13
7	Akt2 Deficiency Protects from Acute Lung Injury via Alternative Macrophage Activation and miR-146a Induction in Mice The Journal of Immunology ·Eleni Vergadi,Katerina Vaporidi,Emmanuel Theodorakis,Christina Doxaki,Eleni Lagoudaki,Eleftheria Ieronymaki,Vasileia Ismini Alexaki,Mike W. Helms,Εumorfia Kondili,Birte Soennichsen,Efstathios N. Stathopoulos,Andrew N. Margioris,Dimitrios Georgopoulos,Christos Tsatsanis	2013	135
8	Image-guided genomic analysis of tissue response to laser-induced thermal stress Journal of Biomedical Optics ·Mark A. Mackanos,Mike W. Helms,Flora Kalish,Christopher H. Contag	2011	5
9	IL-12 enhances efficacy and shortens enrichment time in cytokine-induced killer cell immunotherapy Cancer Immunology Immunotherapy ·Mike W. Helms,Jennifer A. Prescher,Yuan Cao,Steven Schaffert,Christopher H. Contag	2010	46
10	TOB1 Is Regulated by EGF-Dependent HER2 and EGFR Signaling, Is Highly Phosphorylated, and Indicates Poor Prognosis in Node-Negative Breast Cancer Cancer Research ·Mike W. Helms,Dirk Kemming,Christopher H. Contag,Heike Pospisil,Kai Bartkowiak,Alice Wang,Sheng-Yung Chang,Horst Buerger,Burkhard Brandt	2009	33
11	Quantifying Cell-Surface Biomarker Expression in Thick Tissues with Ratiometric Three-Dimensional Microscopy Biophysical Journal ·Jonathan Liu,Mike W. Helms,Michael J. Mandella,James M. Crawford,G. S. Kino,Christopher H. Contag	2009	55
12	Ratiometric 3D scanning cytometer for quantifying cell-surface biomarker expression within intact tissues Jonathan Liu,Michael J. Mandella,Mike W. Helms,James M. Crawford,Christopher H. Contag,G. S. Kino	2009	2
13	Squalene epoxidase, located on chromosome 8q24.1, is upregulated in 8q+ breast cancer and indicates poor clinical outcome in stage I and II disease British Journal of Cancer ·Mike W. Helms,Dirk Kemming,Heike Pospisil,U Vogt,Horst Buerger,Eberhard Korsching,C Liedtke,C. M. Schlotter,APRIL WANG,Stephen Chan,Burkhard Brandt	2008	47
14	Options for Visualizing Metastatic Disease in the Living Body PubMed ·Mike W. Helms,Burkhard Brandt,Christopher H. Contag	2006	2
15	Whole Genome Expression Analysis for Biologic Rational Pathway Modeling Molecular Diagnosis & Therapy ·Dirk Kemming,U Vogt,Nicola Tidow,C. M. Schlotter,Horst Bürger,Mike W. Helms,Eberhard Korsching,A Granetzny,A. Boseila,Ludger Hillejan,Alessandro Marra,Yavuz Ergönenc,H. Adigüzel,Burkhard Brandt	2006	8
16	[Expression of early placenta insulin-like growth factor (EPIL) in breast cancer cells provides an autocrine loop with enhancement of predominantly HER-2-related invasivity]. PubMed ·Horst Bürger,Dirk Kemming,Mike W. Helms,U. Feldmann,A. Matuschek,W. Böcker,B. Brandt	2005	2
17	Expression of early placenta insulin-like growth factor in breast cancer cells provides an autocrine loop that predominantly enhances invasiveness and motility Endocrine Related Cancer ·Burkhard Brandt,Dirk Kemming,Jens Packeisen,Ronald Simon,Mike W. Helms,U. Feldmann,A. Matuschek,Christian Kersting,Bernd Hinrichs,J-M Bidart,D Bellet,Kai Bartkowiak,N Dankbar,Thomas Dittmar,Guido Sauter,Werner Boecker,Horst Buerger	2005	20
18	First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor‐positive breast cancer The Journal of Pathology ·Mike W. Helms,Jens Packeisen,Christian August,Birgit Schittek,Werner Boecker,Burkhard Brandt,Horst Buerger	2005	75
19	Deciphering a subgroup of breast carcinomas with putative progression of grade during carcinogenesis revealed by comparative genomic hybridisation (CGH) and immunohistochemistry British Journal of Cancer ·Eberhard Korsching,Jens Packeisen,Mike W. Helms,Christian Kersting,(unknown),P. J. van Diest,Burkhard Brandt,Elsken van der Wall,Werner Boecker,Horst Bürger	2004	26
20	Activation Mechanism of Pro-astacin: Role of the Pro-peptide, Tryptic and Autoproteolytic Cleavage and Importance of Precise Amino-terminal Processing Journal of Molecular Biology ·Irene Yiallouros,Reinhild Kappelhoff,Oliver Schilling,Frank Wegmann,Mike W. Helms,Astrid Auge,Gertrud Brachtendorf,Eva Große Berkhoff,Bernd Beermann,Hans‐Jürgen Hinz,Simone König,Jasna Peter‐Katalinić,Walter Stöcker	2002	38

About Mike W. Helms

Mike W. Helms is a scholar working on Biophysics, Cancer Research and Molecular Biology, having authored 21 papers that have together received 591 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (4 papers), Advanced biosensing and bioanalysis techniques (4 papers), RNA Research and Splicing (2 papers), Estrogen and related hormone effects (2 papers), Immune Response and Inflammation (2 papers), HER2/EGFR in Cancer Research (2 papers), Cell Image Analysis Techniques (2 papers) and Gene expression and cancer classification (2 papers). The work is most often cited by research in Cancer Research (155 citations), Immunology (148 citations) and Oncology (131 citations). Mike W. Helms has collaborated with scholars based in Germany, United States and Belgium. Frequent co-authors include Burkhard Brandt, Christopher H. Contag, Horst Buerger, Werner Boecker, Jens Packeisen, Christos Tsatsanis, Christina Doxaki, Birgit Schittek, Christian August and Dirk Kemming. Their work appears in journals such as The Journal of Immunology, Journal of Molecular Biology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact